Business Context and Reporting Period
This Form 8-K Current Report from SANUWAVE Health, Inc. covers events occurring through January 31, 2011. The filing details the conclusion of an option exercise period related to a 2010 private placement offering conducted under Rule 506 of Regulation D.
Key Financial Metrics
- Gross Proceeds: $4,102,660 raised from the exercise of options.
- Securities Issued: 2,051,330 shares of Common Stock and 2,051,330 Class D Warrants.
- Exercise Price: $2.00 per Unit (comprising one share and one warrant).
- Unexercised Options: 132,500 options expired unexercised as of January 31, 2011.
Material Changes
The primary material change reported is the extension of the option expiration date from December 31, 2010, to January 31, 2011, by the Board of Directors. This extension allowed for the exercise of 2,051,330 options, resulting in significant capital inflow. The filing does not provide comparative financial data for prior periods regarding revenue, profit, or debt levels.
Outlook, Risks, and Unusual Items
The filing notes that Kevin A. Richardson II, the Chairman of the Board, participated in the transaction by exercising a portion of his options. No forward-looking guidance, risk factors, or management commentary regarding future operations is included in this specific report. The filing focuses strictly on the mechanics of the unregistered sale of equity securities.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance of the 2,051,330 new shares.
- Confirm the terms and expiration dates of the newly issued 2,051,330 Class D Warrants.
- Review the company's cash position to confirm the receipt of the $4,102,660 in gross proceeds.
- Check for any subsequent filings regarding the use of proceeds from this offering.